Clinical Scorecard: ICU Advances Improve Acute Liver Failure
At a Glance
| Category | Detail |
|---|---|
| Condition | Acute Liver Failure (ALF) |
| Key Mechanisms | Hepatic encephalopathy, hyperdynamic circulatory state, acute kidney injury, coagulation abnormalities |
| Target Population | Patients with acute liver failure without preexisting liver disease |
| Care Setting | Intensive Care Unit (ICU) |
Key Highlights
- Mortality rates in ALF have declined from 85% to approximately 55%.
- Hepatic encephalopathy is a major cause of mortality, with ammonia levels predicting severity.
- Early initiation of continuous renal replacement therapy is recommended for patients with rising ammonia levels.
- Noninvasive neuromonitoring is preferred over invasive intracranial pressure monitoring.
- Multidisciplinary management improves outcomes significantly.
Guideline-Based Recommendations
Diagnosis
- ALF is diagnosed with an INR or prothrombin time > 1.5 and hepatic encephalopathy onset within 4 weeks.
Management
- Crystalloid resuscitation with normal saline is preferred; vasopressor therapy is indicated if hypotension persists.
Monitoring & Follow-up
- Noninvasive neuromonitoring tools should be utilized; avoid invasive intracranial pressure monitoring.
Risks
- Invasive monitoring has a risk of intracranial bleeding in 10% of patients.
Patient & Prescribing Data
Approximately 2,000 to 3,000 cases of ALF annually in the US.
Continuous renal replacement therapy is preferred for hemodynamic stability.
Clinical Best Practices
- Rapid transfer to specialized centers improves survival rates.
- Utilize viscoelastic testing for better coagulation assessment.
- Implement standardized protocols for managing multiorgan failure.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
